The board of directors of biopharmaceutical company Pfizer Inc (NYSE:PFE) declared the company's 321st consecutive dividend of USD0.36 of its common stock for the first quarter 2019, it reported on Friday.
This new dividend marks a growth of approximately 6% from the prior dividend of USD0.34 per share of its common stock.
Shareholders of record at the close of business as of 1 February 2019 will receive the dividend on 1 March 2019,
Additionally, the board of directors has launched a new USD10bn share repurchase programme,which is in addition to the USD4.9bn remaining under its current authorisation.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva